glp 1 for alcohol cravings GLP-1 Anti-Obesity Rx and and Substance Use Disorders Popular weight loss, diabetes drug

The rise corresponds with the established effectiveness of GLP-1 RAs, such as semaglutide and liraglutide, for significant weight loss in people with obesity a group representing roughly 93 million potentially eligible U.S

However, this was not significantly different between both chronic AIH groups (p=0.4 and p=0.9 for ALT and bilirubin)

Key Takeaways Two Active Ingredients, Five Products GLP-1 Market Represents a Financialized Business Model Prolonged Patent Protection & Market Exclusivity Two Active Ingredients, Five Products: Semaglutide is marketed by Novo Nordisk as three separate drug products under the brand names: Ozempic (injection for diabetes, approved in 2017), Rybelsus (oral tablet for diabetes, approved in 2019), and Wegovy (injection for weight loss, approved in 2021)

In this briefing, we use the Category Advantage research framework

Impact of semaglutide on biochemical and radiologic measures of metabolic-dysfunction associated fatty liver disease across the spectrum of glycaemia: A meta-analysis

10.1016/j.cell.2016.05.041 Cell